Benzinga
Benzinga
Benzinga
domenica, settembre 20

Accendra Health Inc

ACHNYSE
Trade with Public
Trade with Public
$0.8897
-0.14-13.62%
In chiusura: Sep 18, 5:00 PM EST
$0.9280
0.03834.3%
Post-mercato: Sep 18, 7:39 PM EST
PanoramicaNotiziePrevisioni utiliObiettivi di prezzoDati finanziariSentimentConfrontaOpzioniRapporto azionario

Accendra Health Financials

Accendra Health (ACH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Accendra Health Q2 Adj. EPS $(0.19) Misses $(0.09) Estimate, Sales $613.200M Miss $627.306M Estimate

Benzinga Newsdesk

PRO
Accendra Health Lowers FY2026 Sales Guidance from $2.550B-$2.650B to $2.450B-$2.550B vs $2.574B Est

Accendra Health (NYSE:ACH) lowers FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.450 billion-$2.550 billion vs $2.574 billion estimate.
Benzinga Newsdesk

PRO
Accendra Health Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.590B Est

Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.550 billion-$2.650 billion vs $2.590 billion estimate.
Benzinga Newsdesk

Earnings Scheduled For May 11, 2026

Benzinga Insights

PRO
Accendra Health Q1 Adj. EPS $(0.04) Beats $(0.10) Estimate, Sales $627.800M Miss $644.636M Estimate

Benzinga Newsdesk

PRO
Accendra Health Sees FY2026 Sales $2.550B-$2.650B vs $2.604B Est

Accendra Health (NYSE:ACH) sees FY2026 sales of $2.550 billion-$2.650 billion vs $2.604 billion analyst estimate.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved